In-Vitro Diagnostics MGR 2017
July 2017
250
About the Report
About the Report
In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person's state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorporated in in-vitro diagnostics are polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. In-vitro diagnostic medical devices include reagents, reagent products, control materials, calibration materials, kits, instruments, apparatus, systems, equipment, pregnancy tests, urine test strips, blood sugar monitoring systems for diabetics and receptacles for medical specimens.
Americas was the largest region in the In-Vitro Diagnostics market in 2016, accounting for over 45% of the market share. Asia was the second largest region accounting for over 22% of the market share. Europe was the third largest region accounting for over 20% of the market share.
Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, In February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature's expertise in both next-generation sequencing (NGS) assays and biobanks. In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space
The In-Vitro Diagnostics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics market.
Reasons to Purchase
Outperform competitors using accurate up to date demand-side dynamics information.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.
Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the In-vitro diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The In-vitro diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider medical equipment market, and compares it with other markets.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
The In-vitro diagnostics market section of the report gives context. It compares the In-vitro diagnostics market with other segments of the medical equipment market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The In-Vitro Diagnostics Indicators Comparison.
The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And Immunohematology
Companies Mentioned: F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., and Thermo Fisher Scientific
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The In-Vitro Diagnostics Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Products
Products
Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And Immunohematology
Companies
F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., and Thermo Fisher Scientific
Table of Contents
Table of Contents
1. In-Vitro Diagnostics Market Characteristics;
2. In-Vitro Diagnostics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. In-Vitro Diagnostics Market Customer Information;
5. In-Vitro Diagnostics Market Segmentation;
5.1. Global In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 5.2. Global In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Segment; 5.3 Global In-Vitro Diagnostics Market Trends And Strategies; Strategic Collaborations And Agreements; New Product Launches; Rising Demand for Point-of-Care (POC) Testing; 5.4 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2016; 5.5 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2012-2020, Historic and Forecast; 5.6 In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Region; 5.7. In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Country; 5.8 Point-Of-Care Diagnostics; 5.8.1 Market Characteristics; 5.8.2. Global Point-Of-Care Diagnostics Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9 Immunochemistry; 5.9.1. Market Characteristics; 5.9.2. Global Immunochemistry Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10 Clinical Chemistry; 5.10.1. Market Characteristics; 5.10.2. Global Clinical Chemistry Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11 Molecular Diagnostics; 5.11.1. Market Characteristics; 5.11.2. Global Molecular Diagnostics Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12 Microbiology; 5.12.1. Market Characteristics; 5.12.2. Global Microbiology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13 Hemostasis; 5.13.1. Market Characteristics; 5.13.2. Global Hemostasis Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14 Hematology And Immunohematology; 5.14.1. Market Characteristics; 5.14.2. Global Hematology And Immunohematology Market, 2016, By Segment; 5.14.3. Market Trends And Strategies;
6. In-Vitro Diagnostics Market Regional And Country Analysis;
6.1. Global In-Vitro Diagnostics Market, 2016, By Region; 6.2. Global In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Region; 6.3. In-Vitro Diagnostics Market, 2016, By Country; 6.4. In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Medical Equipment Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Medical Equipment Market Segments, 2016, By Country
7. Global In-Vitro Diagnostics Market Comparison With Macro Economic Factors;
7.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average In-Vitro Diagnostics Expenditure, Global; 8. In-Vitro Diagnostics Market Comparison With Macro Economic Factors Across Countries; 8.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average In-Vitro Diagnostics Expenditure, By Country;
9. In-Vitro Diagnostics Market Comparison With Industry Metrics; 9.1. Global Number Of Medical Labs, 2016, By Country; 9.2. Global In-Vitro Diagnostics Market Revenue Versus Number Of Medical Labs, 2016, By Country;
10. Asia-Pacific In-Vitro Diagnostics Market;
10.1.1. Asia-Pacific In-Vitro Diagnostics Market Overview; 10.1.2. Asia-Pacific In-Vitro Diagnostics Historic Market, 2012-2016; 10.1.3. Asia-Pacific In-Vitro Diagnostics Forecast Market, 2016-2020; 10.1.4. Asia-Pacific In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.2. Asia-Pacific In-Vitro Diagnostics Market: Country Analysis; 10.3. China In-Vitro Diagnostics Market; 10.3.1. China In-Vitro Diagnostics Market Overview; 10.3.2. China In-Vitro Diagnostics Historic Market, 2012-2016; 10.3.3. China In-Vitro Diagnostics Forecast Market, 2016-2020; 10.3.4. China In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.3.5. China In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020; 10.4. India In-Vitro Diagnostics Market; 10.4.1. India In-Vitro Diagnostics Market Overview; 10.4.2. India In-Vitro Diagnostics Historic Market, 2012-2016; 10.4.3. India In-Vitro Diagnostics Forecast Market, 2016-2020; 10.4.4. India In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.4.5. India In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020; 10.5. Japan In-Vitro Diagnostics Market; 10.5.1. Japan In-Vitro Diagnostics Market Overview; 10.5.2. Japan In-Vitro Diagnostics Historic Market, 2012-2016; 10.5.3. Japan In-Vitro Diagnostics Forecast Market, 2016-2020; 10.5.4. Japan In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.5.5. Japan In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020; 10.6. Australia In-Vitro Diagnostics Market; 10.6.1. Australia In-Vitro Diagnostics Historic Market, 2012-2016; 10.6.2. Australia In-Vitro Diagnostics Forecast Market, 2016-2020; 10.6.3. Australia In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.6.4. Australia In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020;
11. Western Europe In-Vitro Diagnostics Market;
11.1.1. Western Europe In-Vitro Diagnostics Market Overview; 11.1.2. Western Europe In-Vitro Diagnostics Historic Market, 2012-2016; 11.1.3. Western Europe In-Vitro Diagnostics Forecast Market, 2016-2020; 11.1.4. Western Europe In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.2. Western Europe In-Vitro Diagnostics Market: Country Analysis; 11.3. UK In-Vitro Diagnostics Market; 11.3.1. UK In-Vitro Diagnostics Market Overview; 11.3.2. UK In-Vitro Diagnostics Historic Market, 2012-2016; 11.3.3. UK In-Vitro Diagnostics Forecast Market, 2016-2020; 11.3.4. UK In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.3.5. UK In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020; 11.4. Germany In-Vitro Diagnostics Market; 11.4.1. Germany In-Vitro Diagnostics Historic Market, 2012-2016; 11.4.2. Germany In-Vitro Diagnostics Forecast Market, 2016-2020; 11.4.3. Germany In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.4.4 Germany In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020; 11.5 France In-Vitro Diagnostics Market; 11.5.1 France In-Vitro Diagnostics Historic Market, 2012-2016; 11.5.2 France In-Vitro Diagnostics Forecast Market, 2016-2020; 11.5.3 France In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.5.4 France In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020; 11.6. Italy In-Vitro Diagnostics Market; 11.6.1. Italy In-Vitro Diagnostics Historic Market, 2012-2016; 11.6.2. Italy In-Vitro Diagnostics Forecast Market, 2016-2020; 11.6.3. Italy In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.6.4. Italy In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020; 11.7. Spain In-Vitro Diagnostics Market; 11.7.1. Spain In-Vitro Diagnostics Historic Market, 2012-2016; 11.7.2. Spain In-Vitro Diagnostics Forecast Market, 2016-2020; 11.7.3. Spain In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.7.4. Spain In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020;
12. Eastern Europe In-Vitro Diagnostics Market;
12.1.1. Eastern Europe In-Vitro Diagnostics Market Overview; 12.1.2. Eastern Europe In-Vitro Diagnostics Historic Market, 2012-2016; 12.1.3. Eastern Europe In-Vitro Diagnostics Forecast Market, 2016-2020; 12.1.4 Eastern Europe In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 12.2. Eastern Europe In-Vitro Diagnostics Market: Country Analysis; 12.3. Russia In-Vitro Diagnostics Market; 12.3.1. Russia In-Vitro Diagnostics Historic Market, 2012-2016; 12.3.2. Russia In-Vitro Diagnostics Forecast Market, 2016-2020; 12.3.3. Russia In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 12.3.4. Russia In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020;
13. North America In-Vitro Diagnostics Market;
13.1.1. North America In-Vitro Diagnostics Market Overview; 13.1.2. North America In-Vitro Diagnostics Historic Market, 2012-2016; 13.1.3. North America In-Vitro Diagnostics Forecast Market, 2016-2020; 13.1.4. North America In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; 13.2. North America In-Vitro Diagnostics Market: Country Analysis; 13.3. USA In-Vitro Diagnostics Market; 13.3.1. USA In-Vitro Diagnostics Historic Market, 2012-2016; 13.3.2. USA In-Vitro Diagnostics Forecast Market, 2016-2020; 13.3.3 USA In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 13.3.4. USA In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020;
14. South America In-Vitro Diagnostics Market;
14.1.1. South America In-Vitro Diagnostics Market Overview; 14.1.2. South America In-Vitro Diagnostics Historic Market, 2012-2016; 14.1.3. South America In-Vitro Diagnostics Forecast Market, 2016-2020; 14.1.4. South America In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 14.2. South America In-Vitro Diagnostics Market: Country Analysis; 14.3. Brazil In-Vitro Diagnostics Market; 14.3.1. Brazil In-Vitro Diagnostics Historic Market, 2012-2016; 14.3.2. Brazil In-Vitro Diagnostics Forecast Market, 2016-2020; 14.3.3. Brazil In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 14.3.4. Brazil In-Vitro Diagnostics Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020;
15. Middle East In-Vitro Diagnostics Market;
15.1.1. Middle East In-Vitro Diagnostics Market Overview; 15.1.2. Middle East In-Vitro Diagnostics Historic Market, 2012-2016; 15.1.3. Middle East In-Vitro Diagnostics Forecast Market, 2016-2020; 15.1.4. Middle East In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology;
16. Africa In-Vitro Diagnostics Market;
16.1.1. Africa In-Vitro Diagnostics Market Overview; 16.1.2. Africa In-Vitro Diagnostics Historic Market, 2012-2016; 16.1.3. Africa In-Vitro Diagnostics Forecast Market, 2016-2020; 16.1.4. Africa In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology;
17. In-Vitro Diagnostics Market Competitive Landscape;
17.1. Company Profiles; 17.2. F. Hoffmann-La Roche Ltd; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Siemens Healthineers; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Danaher (Beckman Coulter Inc); 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Abbott Laboratories Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Thermo Fisher Scientific; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The In-Vitro Diagnostics Market;
19. Market Background: Medical Equipment Market;
19.1.1. Medical Equipment Market Characteristics; 19.1.2. Medical Equipment Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Medical Equipment Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Medical Equipment Trends And Strategies; 19.2. Medical Equipment Market Regional And Country Analysis; 19.2.1. Global Medical Equipment Market, 2016, By Region; 19.2.2. Global Medical Equipment Market, 2012-2020, Historic And Forecast, By Region; 19.3.3. Medical Equipment Market, 2016, By Country; 19.2.4. Medical Equipment Market, 2012-2020, Historic And Forecast, By Country; 19.2.5. Global Medical Equipment Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Medical Equipment Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Medical Equipment Market Comparison With Macro Economic Factors; 19.3.1. Medical Equipment Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Medical Equipment Expenditure, Global; 19.4. Medical Equipment Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Medical Equipment Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Medical Equipment Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Medical Equipment Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
List of Figure
Table 1: Global In-Vitro Diagnostics Historic Market Growth
Table 2: Global In-Vitro Diagnostics Forecast Market Growth
Table 3: In-Vitro Diagnostics Market Segmentation
Table 4: Global In-Vitro Diagnostics Market, 2016, By Segment
Table 5: Global In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Segment
Table 6: Global In-Vitro Diagnostics Market Compared With Similar Markets, 2016
Table 7: Global In-Vitro Diagnostics Market Compared With Similar Markets, 2012-2020, Historic and Forecast
Table 8: In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Region
Table 9: In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Country
Table 10: Global Point-Of-Care Diagnostics Market, 2016, By Segment
Table 11: Global Immunochemistry Market, 2016, By Segment
Table 12: Global Clinical Chemistry Market, 2016, By Segment
Table 13: Global Molecular Diagnostics Market, 2016, By Segment
Table 14: Global Microbiology Market, 2016, By Segment
Table 15: Global Hemostasis Market, 2016, By Segment
Table 16: Global Hematology And Immunohematology Market, 2016, By Segment
Table 17: Global In-Vitro Diagnostics Market, 2016, By Region
Table 18: Global In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Region
Table 19: In-Vitro Diagnostics Market, 2016, By Country
Table 20: In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Country
Table 21: Global Healthcare Market Segments, 2016, By Region
Table 22: Global Medical Equipment Market Segments, 2016, By Region
Table 23: Global Healthcare Market Segments, 2016, By Country
Table 24: Global Medical Equipment Market Segments, 2016, By Country
Table 25: In-Vitro Diagnostics Market Size, Percentage Of GDP, Global
Table 26: Per Capita Average In-Vitro Diagnostics Expenditure, Global
Table 27: In-Vitro Diagnostics Market Comparison With Macro Economic Factors Across Countries
Table 28: In-Vitro Diagnostics Market Size, Percentage Of GDP, By Country
Table 29: Per Capita Average In-Vitro Diagnostics Expenditure, By Country
Table 30: Global Number Of Medical Labs, 2016, By Country
Table 31: Global In-Vitro Diagnostics Market Revenue Versus Number Of Medical Labs, 2016, By Country
Table 32: Asia-Pacific In-Vitro Diagnostics Historic Market, 2012-2016
Table 33: Asia-Pacific In-Vitro Diagnostics Forecast Market, 2016-2020
Table 34: Asia-Pacific In-Vitro Diagnostics Market, 2016, By Segment
Table 35: China In-Vitro Diagnostics Historic Market, 2012-2016
Table 36: China In-Vitro Diagnostics Forecast Market, 2016-2020
Table 37: China In-Vitro Diagnostics Market, 2016, By Segment
Table 38: China In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 39: China Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 40: India In-Vitro Diagnostics Historic Market, 2012-2016
Table 41: India In-Vitro Diagnostics Forecast Market, 2016-2020
Table 42: India In-Vitro Diagnostics Market, 2016, By Segment
Table 43: India In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 44: India Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 45: Japan In-Vitro Diagnostics Historic Market, 2012-2016
Table 46: Japan In-Vitro Diagnostics Forecast Market, 2016-2020
Table 47: Japan In-Vitro Diagnostics Market, 2016, By Segment
Table 48: Japan In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 49: Japan Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 50: Australia In-Vitro Diagnostics Historic Market, 2012-2016
Table 51: Australia In-Vitro Diagnostics Forecast Market, 2016-2020
Table 52: Australia In-Vitro Diagnostics Market, 2016, By Segment
Table 53: Australia In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 54: Australia Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 55: Western Europe In-Vitro Diagnostics Historic Market, 2012-2016
Table 56: Western Europe In-Vitro Diagnostics Forecast Market, 2016-2020
Table 57: Western Europe In-Vitro Diagnostics Market, 2016, By Segment
Table 58: UK In-Vitro Diagnostics Historic Market, 2012-2016
Table 59: UK In-Vitro Diagnostics Forecast Market, 2016-2020
Table 60: UK In-Vitro Diagnostics Market, 2016, By Segment
Table 61: UK In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 62: UK Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 63: Germany In-Vitro Diagnostics Historic Market, 2012-2016
Table 64: Germany In-Vitro Diagnostics Forecast Market, 2016-2020
Table 65: Germany In-Vitro Diagnostics Market, 2016, By Segment
Table 66: Germany In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 67: Germany Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 68: France In-Vitro Diagnostics Historic Market, 2012-2016
Table 69: France In-Vitro Diagnostics Forecast Market, 2016-2020
Table 70: France In-Vitro Diagnostics Market, 2016, By Segment
Table 71: France In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 72: France Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 73: Italy In-Vitro Diagnostics Historic Market, 2012-2016
Table 74: Italy In-Vitro Diagnostics Forecast Market, 2016-2020
Table 75: Italy In-Vitro Diagnostics Market, 2016, By Segment
Table 76: Italy In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 77: Italy Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 78: Spain In-Vitro Diagnostics Historic Market, 2012-2016
Table 79: Spain In-Vitro Diagnostics Forecast Market, 2016-2020
Table 80: Spain In-Vitro Diagnostics Market, 2016, By Segment
Table 81: Spain In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 82: Spain Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 83: Eastern Europe In-Vitro Diagnostics Historic Market, 2012-2016
Table 84: Eastern Europe In-Vitro Diagnostics Forecast Market, 2016-2020
Table 85: Eastern Europe In-Vitro Diagnostics Market, 2016, By Segment
Table 86: Russia In-Vitro Diagnostics Historic Market, 2012-2016
Table 87: Russia In-Vitro Diagnostics Forecast Market, 2016-2020
Table 88: Russia In-Vitro Diagnostics Market, 2016, By Segment
Table 89: Russia In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 90: Russia Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 91: North America In-Vitro Diagnostics Historic Market, 2012-2016
Table 92: North America In-Vitro Diagnostics Forecast Market, 2016-2020
Table 93: North America In-Vitro Diagnostics Market, 2016, By Segment
Table 94: USA In-Vitro Diagnostics Historic Market, 2012-2016
Table 95: USA In-Vitro Diagnostics Forecast Market, 2016-2020
Table 96: USA In-Vitro Diagnostics Market, 2016, By Segment
Table 97: USA In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 98: USA Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 99: South America In-Vitro Diagnostics Historic Market, 2012-2016
Table 100: South America In-Vitro Diagnostics Forecast Market, 2016-2020
Table 101: South America In-Vitro Diagnostics Market, 2016, By Segment
Table 102: Brazil In-Vitro Diagnostics Historic Market, 2012-2016
Table 103: Brazil In-Vitro Diagnostics Forecast Market, 2016-2020
Table 104: Brazil In-Vitro Diagnostics Market, 2016, By Segment
Table 105: Brazil In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Table 106: Brazil Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Table 107: Middle East In-Vitro Diagnostics Historic Market, 2012-2016
Table 108: Middle East In-Vitro Diagnostics Forecast Market, 2016-2020
Table 109: Middle East In-Vitro Diagnostics Market, 2016, By Segment
Table 110: Africa In-Vitro Diagnostics Historic Market, 2012-2016
Table 111: Africa In-Vitro Diagnostics Forecast Market, 2016-2020
Table 112: Africa In-Vitro Diagnostics Market, 2016, By Segment
Table 113: F. Hoffmann-La Roche Ltd Financial Performance
Table 114: Siemens Healthineers Financial Performance
Table 115: Danaher (Beckman Coulter Inc) Financial Performance
Table 116: Abbott Laboratories Inc. Financial Performance
Table 117: Thermo Fisher Scientific Financial Performance
Table 118: Medical Equipment Market Historic Growth
Table 119: Medical Equipment Market Forecast Growth
Table 120: Global Medical Equipment Market, 2016, By Region
Table 121: Global Medical Equipment Market, 2012-2020, Historic And Forecast, By Region
Table 122: Medical Equipment Market, 2016, By Country
Table 123: Medical Equipment Market, 2012-2020, Historic And Forecast, By Country
Table 124: Global Medical Equipment Market, Growth And Market Share Comparison, By Segment
Table 125: Global Medical Equipment Market, Growth And Market Share Comparison, By Country And Segment
Table 126: Medical Equipment Market Size, Percentage Of GDP, Global
Table 127: Per Capita Average Medical Equipment Expenditure, Global
Table 128: Medical Equipment Market Comparison With Macro Economic Factors Across Countries
Table 129: Medical Equipment Market Size, Percentage Of GDP, By Country
Table 130: Per Capita Average Medical Equipment Expenditure, By Country
Table 131: Healthcare Industry Financial Margins
List of Table
Figure 1: Global In-Vitro Diagnostics Historic Market Growth
Figure 2: Global In-Vitro Diagnostics Forecast Market Growth
Figure 3: In-Vitro Diagnostics Market Segmentation
Figure 4: Global In-Vitro Diagnostics Market, 2016, By Segment
Figure 5: Global In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Segment
Figure 6: Global In-Vitro Diagnostics Market Compared With Similar Markets, 2016
Figure 7: Global In-Vitro Diagnostics Market Compared With Similar Markets, 2012-2020, Historic and Forecast
Figure 8: In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Region
Figure 9: In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Country
Figure 10: Global Point-Of-Care Diagnostics Market, 2016, By Segment
Figure 11: Global Immunochemistry Market, 2016, By Segment
Figure 12: Global Clinical Chemistry Market, 2016, By Segment
Figure 13: Global Molecular Diagnostics Market, 2016, By Segment
Figure 14: Global Microbiology Market, 2016, By Segment
Figure 15: Global Hemostasis Market, 2016, By Segment
Figure 16: Global Hematology And Immunohematology Market, 2016, By Segment
Figure 17: Global In-Vitro Diagnostics Market, 2016, By Region
Figure 18: Global In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Region
Figure 19: In-Vitro Diagnostics Market, 2016, By Country
Figure 20: In-Vitro Diagnostics Market, 2012-2020, Historic And Forecast, By Country
Figure 21: Global Healthcare Market Segments, 2016, By Region
Figure 22: Global Medical Equipment Market Segments, 2016, By Region
Figure 23: Global Healthcare Market Segments, 2016, By Country
Figure 24: Global Medical Equipment Market Segments, 2016, By Country
Figure 25: In-Vitro Diagnostics Market Size, Percentage Of GDP, Global
Figure 26: Per Capita Average In-Vitro Diagnostics Expenditure, Global
Figure 27: In-Vitro Diagnostics Market Comparison With Macro Economic Factors Across Countries
Figure 28: In-Vitro Diagnostics Market Size, Percentage Of GDP, By Country
Figure 29: Per Capita Average In-Vitro Diagnostics Expenditure, By Country
Figure 30: Global Number Of Medical Labs, 2016, By Country
Figure 31: Global In-Vitro Diagnostics Market Revenue Versus Number Of Medical Labs, 2016, By Country
Figure 32: Asia-Pacific In-Vitro Diagnostics Historic Market, 2012-2016
Figure 33: Asia-Pacific In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 34: Asia-Pacific In-Vitro Diagnostics Market, 2016, By Segment
Figure 35: China In-Vitro Diagnostics Historic Market, 2012-2016
Figure 36: China In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 37: China In-Vitro Diagnostics Market, 2016, By Segment
Figure 38: China In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 39: China Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 40: India In-Vitro Diagnostics Historic Market, 2012-2016
Figure 41: India In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 42: India In-Vitro Diagnostics Market, 2016, By Segment
Figure 43: India In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 44: India Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 45: Japan In-Vitro Diagnostics Historic Market, 2012-2016
Figure 46: Japan In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 47: Japan In-Vitro Diagnostics Market, 2016, By Segment
Figure 48: Japan In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 49: Japan Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 50: Australia In-Vitro Diagnostics Historic Market, 2012-2016
Figure 51: Australia In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 52: Australia In-Vitro Diagnostics Market, 2016, By Segment
Figure 53: Australia In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 54: Australia Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 55: Western Europe In-Vitro Diagnostics Historic Market, 2012-2016
Figure 56: Western Europe In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 57: Western Europe In-Vitro Diagnostics Market, 2016, By Segment
Figure 58: UK In-Vitro Diagnostics Historic Market, 2012-2016
Figure 59: UK In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 60: UK In-Vitro Diagnostics Market, 2016, By Segment
Figure 61: UK In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 62: UK Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 63: Germany In-Vitro Diagnostics Historic Market, 2012-2016
Figure 64: Germany In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 65: Germany In-Vitro Diagnostics Market, 2016, By Segment
Figure 66: Germany In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 67: Germany Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 68: France In-Vitro Diagnostics Historic Market, 2012-2016
Figure 69: France In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 70: France In-Vitro Diagnostics Market, 2016, By Segment
Figure 71: France In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 72: France Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 73: Italy In-Vitro Diagnostics Historic Market, 2012-2016
Figure 74: Italy In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 75: Italy In-Vitro Diagnostics Market, 2016, By Segment
Figure 76: Italy In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 77: Italy Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 78: Spain In-Vitro Diagnostics Historic Market, 2012-2016
Figure 79: Spain In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 80: Spain In-Vitro Diagnostics Market, 2016, By Segment
Figure 81: Spain In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 82: Spain Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 83: Eastern Europe In-Vitro Diagnostics Historic Market, 2012-2016
Figure 84: Eastern Europe In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 85: Eastern Europe In-Vitro Diagnostics Market, 2016, By Segment
Figure 86: Russia In-Vitro Diagnostics Historic Market, 2012-2016
Figure 87: Russia In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 88: Russia In-Vitro Diagnostics Market, 2016, By Segment
Figure 89: Russia In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 90: Russia Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 91: North America In-Vitro Diagnostics Historic Market, 2012-2016
Figure 92: North America In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 93: North America In-Vitro Diagnostics Market, 2016, By Segment
Figure 94: USA In-Vitro Diagnostics Historic Market, 2012-2016
Figure 95: USA In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 96: USA In-Vitro Diagnostics Market, 2016, By Segment
Figure 97: USA In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 98: USA Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 99: South America In-Vitro Diagnostics Historic Market, 2012-2016
Figure 100: South America In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 101: South America In-Vitro Diagnostics Market, 2016, By Segment
Figure 102: Brazil In-Vitro Diagnostics Historic Market, 2012-2016
Figure 103: Brazil In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 104: Brazil In-Vitro Diagnostics Market, 2016, By Segment
Figure 105: Brazil In-Vitro Diagnostics Percentage Of GDP, 2012-2020
Figure 106: Brazil Per Capita Average In-Vitro Diagnostics Expenditure, 2012-2020
Figure 107: Middle East In-Vitro Diagnostics Historic Market, 2012-2016
Figure 108: Middle East In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 109: Middle East In-Vitro Diagnostics Market, 2016, By Segment
Figure 110: Africa In-Vitro Diagnostics Historic Market, 2012-2016
Figure 111: Africa In-Vitro Diagnostics Forecast Market, 2016-2020
Figure 112: Africa In-Vitro Diagnostics Market, 2016, By Segment
Figure 113: F. Hoffmann-La Roche Ltd Financial Performance
Figure 114: Siemens Healthineers Financial Performance
Figure 115: Danaher (Beckman Coulter Inc) Financial Performance
Figure 116: Abbott Laboratories Inc. Financial Performance
Figure 117: Thermo Fisher Scientific Financial Performance
Figure 118: Medical Equipment Market Historic Growth
Figure 119: Medical Equipment Market Forecast Growth
Figure 120: Global Medical Equipment Market, 2016, By Region
Figure 121: Global Medical Equipment Market, 2012-2020, Historic And Forecast, By Region
Figure 122: Medical Equipment Market, 2016, By Country
Figure 123: Medical Equipment Market, 2012-2020, Historic And Forecast, By Country
Figure 124: Global Medical Equipment Market, Growth And Market Share Comparison, By Segment
Figure 125: Global Medical Equipment Market, Growth And Market Share Comparison, By Country And Segment
Figure 126: Medical Equipment Market Size, Percentage Of GDP, Global
Figure 127: Per Capita Average Medical Equipment Expenditure, Global
Figure 128: Medical Equipment Market Comparison With Macro Economic Factors Across Countries
Figure 129: Medical Equipment Market Size, Percentage Of GDP, By Country
Figure 130: Per Capita Average Medical Equipment Expenditure, By Country
Figure 131: Healthcare Industry Financial Margins
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.